{"url_path":"/sec/mgnx/8-k/2026-07-07/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-07","source_url":"https://www.sec.gov/Archives/edgar/data/1125345/0001125345-26-000045-index.html","accession_number":"0001125345-26-000045","cik":"0001125345","ticker":"MGNX","issuer_name":"MACROGENICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1125345/0001125345-26-000045-index.html","primary_entity_key":"0001125345","primary_entity_name":"MACROGENICS INC"},"word_count":143,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits\n\n(b) Pro Forma Financial Information.\n\nFiled herewith as Exhibit 99.2 are the unaudited pro forma consolidated balance sheet as of March 31, 2026, and the unaudited pro forma consolidated statements of operations for the year ended December 31, 2025 and the three months ended March 31, 2026, each giving effect to the disposition of the CDMO Operations.\n\n(d) Exhibits.\n\nExhibit NumberDescription of Exhibit\n\n[99.1](exhibit99-1boraclosepressr.htm)\n\n[Press Release dated](exhibit99-1boraclosepressr.htm)[July 2](exhibit99-1boraclosepressr.htm)[, 2026](exhibit99-1boraclosepressr.htm)\n\n[99.2](exhibit99-2proforma.htm)\n\n[Unaudited Consolidated Pro Forma Financial Information](exhibit99-2proforma.htm)\n\n104Cover Page Interactive Data (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: July 7, 2026\nMACROGENICS, INC.\n\nBy:\n\n/s/ Jeffrey Peters\n\nJeffrey Peters\n\nSenior Vice President, General Counsel and Corporate Secretary"}